TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Unimedic Pharma AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
34,347
|
28,351
|
24,274 |
Financial expenses |
342
|
191
|
106 |
Earnings before taxes |
6,594
|
6,069
|
2,950 |
EBITDA |
7,465
|
6,889
|
3,670 |
Total assets |
17,972
|
17,864
|
13,353 |
Current assets |
16,618
|
15,888
|
11,045 |
Current liabilities |
5,182
|
7,640
|
5,947 |
Equity capital |
6,821
|
3,313
|
1,977 |
- share capital |
18
![]() |
18
|
20 |
Employees (average) |
27
![]() |
27
|
25 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
38.0%
|
18.5%
|
14.8% |
Turnover per employee |
1,272
|
1,050
|
971 |
Profit as a percentage of turnover |
19.2%
|
21.4%
|
12.2% |
Return on assets (ROA) |
38.6%
|
35.0%
|
22.9% |
Current ratio |
320.7%
|
208.0%
|
185.7% |
Return on equity (ROE) |
96.7%
|
183.2%
|
149.2% |
Change turnover |
5,913
|
6,043
|
528 |
Change turnover % |
21%
|
27%
|
2% |
Chg. No. of employees |
0
|
2
![]() |
2 |
Chg. No. of employees % |
0%
|
8%
|
9% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.